Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis

JAMA

Volumn 304, Issue 19, 2010, Pages 2145-2153

  Aaron, Shawn D ^a   Vandemheen, Katherine L ^a   Ramotar, Karam ^a   Giesbrecht Lewis, Tracy ^a   Tullis, Elizabeth ^b   Freitag, Andreas ^c   Paterson, Nigel ^d   Jackson, Mary ^e   Lougheed, M Diane ^f   Dowson, Christopher ^g   Kumar, Vijay ^h   Ferris, Wendy ⁱ   Chan, Francis ⁱ   Doucette, Steve ^a   Fergusson, Dean ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e GRAND RIVER HOSPITAL   (Canada)

^f QUEEN S UNIVERSITY   (Canada)

^g UNIVERSITY OF WARWICK   (United Kingdom)

^h SUDBURY REGIONAL HOSPITAL   (Canada)

ⁱ CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; COLISTIN; DORNASE ALFA; GENOMIC DNA; TOBRAMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BACTERIUM ISOLATE; CANADA; COHORT ANALYSIS; COMORBIDITY; CYSTIC FIBROSIS; DEATH; DISEASE TRANSMISSION; FEMALE; GENOTYPE; HUMAN; INFECTION RATE; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; RISK; SPUTUM CULTURE; STRAIN IDENTIFICATION; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 78349270511     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1665     Document Type: Article

References (28)

1. Döring G, Conway SP, Heijerman HG, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J. 2000;16(4):749-767.
2. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol. 1996;143(10):1007-1017.
3. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91-100.
4. Burns JL, Emerson J, Stapp JR, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998;27(1):158-163.
5. Ramsey BW. To cohort or not to cohort: how transmissible is Pseudomonas aeruginosa? Am J Respir Crit Care Med. 2002;166(7):906-907.
6. Grothues D, Koopmann U, von der Hardt H, Tümmler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol. 1988;26(10):1973-1977.
7. Cheng K, Smyth RL, Govan JRW, et al. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 1996;348(9028):639- 642.
8. Winstanley C, Langille MG, Fothergill JL, et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool epidemic strain of Pseudomonas aeruginosa. Genome Res. 2009;19(1):12-23.
9. Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol. 2004;53(pt 7):609-615.
10. Armstrong DS, Nixon GM, Carzino R, et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med. 2002;166(7):983-987.
11. Griffiths AL, Jamsen K, Carlin JB, et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med. 2005;171(9):1020-1025.
12. Jones AM, Govan JRW, Doherty CJ, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet. 2001;358(9281):557-558.
13. Speert DP, Campbell ME, Henry DA, et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med. 2002;166(7):988-993.
14. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123(6):659-664.
15. Laing FPY, Ramotar K, Read RR, et al. Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment. J Clin Microbiol. 1995;33(3):513-518.
16. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233-2239.
17. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42(12):5644-5649.
18. Waine DJ, Honeybourne D, Smith EG, Whitehouse JL, Dowson CG. Cross-sectional and longitudinal multilocus sequence typing of Pseudomonas aeruginosa in cystic fibrosis sputum samples. J Clin Microbiol. 2009;47(11):3444-3448.
19. Wainwright CE, France MW, O'Rourke P, et al. Cough-generated aerosols of Pseudomonas aeruginosa and other gram-negative bacteria from patients with cystic fibrosis. Thorax. 2009;64(11):926-931.
20. Jones AM, Govan JR, Doherty CJ, et al. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross-infection outbreak. Thorax. 2003;58(6):525-527.
21. McCallum SJ, Gallagher MJ, Corkill JE, Hart CA, Ledson MJ, Walshaw MJ. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax. 2002;57(6):559-560.
22. Mohan K, Fothergill JL, Storrar J, Ledson MJ, Winstanley C, Walshaw MJ. Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat. Thorax. 2008;63(9):839-840.
23. Govan JR, Brown PH, Maddison J, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993;342(8862):15-19.
24. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet. 1990;336(8723):1094-1096.
25. John M, Ecclestone E, Hunter E, Couroux P, Hussain Z. Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis. Pediatr Pulmonol. 1994;18(2):108-113.
26. Aaron SD, Ramotar K, Ferris W, et al. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Am J Respir Crit Care Med. 2004;169(7):811-815. (Pubitemid 38402456)
27. Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax. 2004;59(4):334-336.
28. Jones AM, Dodd ME, Morris J, Doherty C, Govan JR, Webb AK. Clinical outcome for cystic fibrosis patients infected with transmissible Pseudomonas aeruginosa: an 8-year prospective study. Chest. 2010;137(6):1405-1409.